Exercise: Clinical Trials

6 trials of Exercise, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 recruiting. 6 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Recruiting 6
Phase 23Recruiting 3

Follow Exercise: new trials by email Literature Review of Exercise trials Research Report on Exercise

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of INM004 in Children With STEC-HUS
INM004, Placebo - Hemolytic-Uremic Syndrome
Phase 3RecruitingInmunova S.A.2202024-10-052026-01-15
Empagliflozin Reversal of Arterial StiffnEss in Aging
Empagliflozin 10 MG, Placebo - Aging, Arterial Stiffness
Phase 2 / Phase 3RecruitingUniversity of Missouri-Columbia802024-08-182026-02-06
The MUSE Study for Menopausal Arthralgia
Menopausal hormone therapy, Exercise training, Menopausal hormone therapy + exercise training - Arthralgia, Menopause
Phase 2 / Phase 3RecruitingNational University Hospital, Singapore1002024-08-012024-07-31
Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.
Aerobic Exercise, Counseling, Nicotine patch - Nicotine Dependence
Phase 3RecruitingJasper A. Smits3602023-12-272026-05-15
Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects
Lifestyle Intervention, Dasatinib 100 MG, Quercetin 1000mg - Obesity, Healthy Lifestyle
Phase 2 / Phase 3RecruitingCedars-Sinai Medical Center1602023-10-172026-03-18
CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease
CoQ10, Placebo, HB-HIIT - End Stage Renal Disease
Phase 3RecruitingVanderbilt University Medical Center1562023-06-012026-01-02

Conditions studied

Motor Activity (2)  ·  Arthralgia (1)  ·  Frailty (1)  ·  Hemolytic-Uremic Syndrome (1)  ·  Kidney Failure, Chronic (1)  ·  Mitochondrial Diseases (1)  ·  Obesity (1)  ·  Sarcopenia (1)  ·  Tobacco Use Disorder (1)

Sponsors

Cedars-Sinai Medical Center (1)  ·  Inmunova S.A. (1)  ·  Jasper A. Smits (1)  ·  National University Hospital, Singapore (1)  ·  University of Missouri-Columbia (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (4)  ·  Argentina (1)  ·  Belgium (1)  ·  France (1)  ·  Germany (1)  ·  Ireland (1)  ·  Italy (1)  ·  Romania (1)  ·  Singapore (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Baback Roshanravan, MD/MPH (1)  ·  Jasper Smits, PhD (1)  ·  Jorge Gamboa, MD/PhD (1)  ·  Nicolas Musi, MD (1)  ·  Santiago Sanguineti, Ph.D (1)  ·  Talat Ikizler, MD (1)

NIH funding

2023 (1), R01AG075684 (1), R01CA273221 (1)